Legend Biotech LEGN
NASDAQ LEGN
$19.89 +1.07 (+5.69%)
At close: Sep 30, 2026 · 4:00 PM EDT

Legend Biotech (LEGN) EBIT Margin (2019 - 2026)

Updated

Legend Biotech (LEGN) recorded EBIT Margin of 14.89% in Q2 2026, up 23.48 percentage points from -8.58% a year earlier and up 31.21 percentage points from the prior quarter.

Analysis

Legend Biotech (LEGN) EBIT Margin (2019 - 2026) Analysis & Trends

On a TTM basis, Legend Biotech's EBIT Margin came in at -4.35% as of Jun 30, 2026, up 23.67 percentage points year-over-year; for FY2025, it came in at -13.27%, up 36.07 percentage points from FY2024.

  • Annual EBIT Margin has a five-year change of -453.66 percentage points (FY2020 to FY2025).
  • Across earlier years, EBIT Margin came in at -49.34% in FY2024 (+135.89 pp), -185.23% in FY2023 (-585.15 pp), 399.92% in FY2022 (-223.59 pp) and 623.50% in FY2021 (+183.11 pp).
  • The Q2 2026 figure is the highest quarterly EBIT Margin since Q2 2024.
  • On a year-over-year basis, EBIT Margin has increased for four consecutive quarters, with an average year-over-year change of -97.51 percentage points over the last eight quarters.
  • Peak year-over-year performance for EBIT Margin in the last five years was a gain of 1850.47 percentage points in Q2 2023, against a drop of 1173.65 percentage points in Q2 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at -16.32% (Q1 2026), -6.43% (Q4 2025) and -15.96% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 28.21%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 37.86%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -3.52%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 32.97%
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 20.57%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 34.95%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 37.40%
10 Legend Biotech 3.47 Bn -271.48 Mn 251.50 Mn 14.89%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.89%
Mar 31, 2026 -16.32%
Dec 31, 2025 -6.43%
Sep 30, 2025 -15.96%
Jun 30, 2025 -8.58%
Mar 31, 2025 -26.51%
Dec 31, 2024 -42.52%
Sep 30, 2024 -43.92%
Jun 30, 2024 155.02%
Mar 31, 2024 189.15%
Dec 31, 2023 228.28%
Sep 30, 2023 183.82%
Jun 30, 2023 223.92%
Mar 31, 2023 296.72%
Dec 31, 2022 405.70%
Sep 30, 2022 473.89%
Jun 30, 2022 -1,626.55%
Mar 31, 2022 -66.29%
Dec 31, 2021 -228.07%
Sep 30, 2021 -740.19%
API Access

Legend Biotech EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=LEGN&period=max&api_key=YOUR_API_KEY